Comments
Loading...

Viavi Solutions Analyst Ratings

VIAVNASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$16.00
Lowest Price Target1
$8.00
Consensus Price Target1
$12.32

Viavi Solutions Analyst Ratings and Price Targets | NASDAQ:VIAV | Benzinga

Viavi Solutions Inc has a consensus price target of $12.32 based on the ratings of 12 analysts. The high is $16 issued by Argus Research on February 5, 2025. The low is $8 issued by Morgan Stanley on April 8, 2025. The 3 most-recent analyst ratings were released by UBS, B. Riley Securities, and Rosenblatt on May 2, 2025, respectively. With an average price target of $11.83 between UBS, B. Riley Securities, and Rosenblatt, there's an implied 28.00% upside for Viavi Solutions Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
1
Mar
1
1
Apr
2
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

UBS
B. Riley Securities
Rosenblatt
Needham
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Viavi Solutions

Buy NowGet Alert
05/02/2025Buy Now18.98%UBS
Andrew Spinola43%
$11.5 → $11MaintainsNeutralGet Alert
05/02/2025Buy Now18.98%B. Riley Securities
Dave Kang74%
$12 → $11MaintainsNeutralGet Alert
05/02/2025Buy Now46.02%Rosenblatt
Mike Genovese69%
$12 → $13.5MaintainsBuyGet Alert
05/02/2025Buy Now62.25%Needham
Ryan Koontz54%
$15 → $15ReiteratesBuy → BuyGet Alert
04/22/2025Buy Now29.8%Rosenblatt
Mike Genovese69%
$14 → $12MaintainsBuyGet Alert
04/08/2025Buy Now-13.47%Morgan Stanley
Meta Marshall77%
$10 → $8MaintainsUnderweightGet Alert
03/07/2025Buy Now51.43%Rosenblatt
Mike Genovese69%
→ $14UpgradeNeutral → BuyGet Alert
02/05/2025Buy Now73.07%Argus Research
Jim Kelleher74%
$13 → $16MaintainsBuyGet Alert
01/31/2025Buy Now24.39%UBS
Andrew Spinola43%
$10.6 → $11.5MaintainsNeutralGet Alert
01/31/2025Buy Now29.8%B. Riley Securities
Dave Kang74%
$10 → $12MaintainsNeutralGet Alert
01/31/2025Buy Now40.62%Stifel
Ruben Roy81%
$12 → $13ReiteratesBuy → BuyGet Alert
01/31/2025Buy Now8.17%Morgan Stanley
Meta Marshall77%
$9.5 → $10MaintainsUnderweightGet Alert
01/31/2025Buy Now62.25%Needham
Ryan Koontz54%
→ $15UpgradeHold → BuyGet Alert
01/31/2025Buy Now51.43%Northland Capital Markets
Tim Savageaux68%
$13 → $14ReiteratesOutperform → OutperformGet Alert
12/17/2024Buy Now2.76%Morgan Stanley
Meta Marshall77%
$8 → $9.5DowngradeEqual-Weight → UnderweightGet Alert
12/16/2024Buy Now29.8%Stifel
Ruben Roy81%
$10.5 → $12MaintainsBuyGet Alert
12/16/2024Buy NowNeedham
Ryan Koontz54%
ReiteratesHold → HoldGet Alert
11/19/2024Buy Now14.66%UBS
Andrew Spinola43%
→ $10.6Initiates → NeutralGet Alert
11/01/2024Buy Now40.62%Northland Capital Markets
Tim Savageaux68%
$11 → $13MaintainsOutperformGet Alert
11/01/2024Buy Now13.57%Rosenblatt
Mike Genovese69%
$8.25 → $10.5MaintainsNeutralGet Alert
11/01/2024Buy NowNeedham
Ryan Koontz54%
Reiterates → HoldGet Alert
08/09/2024Buy Now-8.06%B. Riley Securities
Dave Kang74%
$9 → $8.5MaintainsNeutralGet Alert
08/09/2024Buy NowNeedham
Ryan Koontz54%
Reiterates → HoldGet Alert
08/06/2024Buy Now13.57%Stifel
Ruben Roy81%
$13 → $10.5MaintainsBuyGet Alert
06/26/2024Buy Now-10.76%Rosenblatt
Mike Genovese69%
$10 → $8.25DowngradeBuy → NeutralGet Alert
05/03/2024Buy Now8.17%Rosenblatt
Mike Genovese69%
$13 → $10MaintainsBuyGet Alert
05/03/2024Buy NowNeedham
Ryan Koontz54%
Reiterates → HoldGet Alert
04/03/2024Buy Now40.62%Rosenblatt
Mike Genovese69%
$15 → $13MaintainsBuyGet Alert
04/01/2024Buy Now40.62%Stifel
Ruben Roy81%
$13 → $13MaintainsBuyGet Alert
04/01/2024Buy NowNeedham
Alex Henderson84%
Reiterates → HoldGet Alert
03/07/2024Buy Now51.43%Susquehanna
Mehdi Hosseini64%
$12 → $14MaintainsPositiveGet Alert
03/06/2024Buy Now83.88%Northland Capital Markets
Tim Savageaux68%
$12 → $17MaintainsOutperformGet Alert
03/06/2024Buy Now18.98%Morgan Stanley
Meta Marshall77%
$9 → $11MaintainsEqual-WeightGet Alert
03/06/2024Buy Now62.25%Rosenblatt
Mike Genovese69%
$13 → $15MaintainsBuyGet Alert
02/12/2024Buy Now40.62%Stifel
Ruben Roy81%
$10 → $13UpgradeHold → BuyGet Alert
12/13/2023Buy Now29.8%Rosenblatt
Mike Genovese69%
$10 → $12MaintainsBuyGet Alert
11/03/2023Buy Now8.17%Rosenblatt
Mike Genovese69%
$14 → $10MaintainsBuyGet Alert
11/03/2023Buy Now-2.65%Morgan Stanley
Connor Lynagh57%
$10 → $9MaintainsEqual-WeightGet Alert
08/31/2023Buy Now51.43%Rosenblatt
Mike Genovese69%
→ $14ReiteratesBuy → BuyGet Alert
08/11/2023Buy Now51.43%Rosenblatt
Mike Genovese69%
$13 → $14MaintainsBuyGet Alert
06/09/2023Buy Now40.62%Rosenblatt
Mike Genovese69%
→ $13ReiteratesBuy → BuyGet Alert
05/03/2023Buy Now8.17%Morgan Stanley
Connor Lynagh57%
$10.5 → $10MaintainsEqual-WeightGet Alert
05/03/2023Buy Now29.8%Susquehanna
Mehdi Hosseini64%
$14 → $12MaintainsPositiveGet Alert
05/03/2023Buy Now40.62%Rosenblatt
Mike Genovese69%
→ $13Reiterates → BuyGet Alert
04/18/2023Buy Now18.98%B. Riley Securities
Dave Kang74%
$13.5 → $11MaintainsNeutralGet Alert
04/18/2023Buy Now51.43%Susquehanna
Mehdi Hosseini64%
$16 → $14MaintainsPositiveGet Alert
04/18/2023Buy Now13.57%Morgan Stanley
Connor Lynagh57%
$13 → $10.5MaintainsEqual-WeightGet Alert
04/18/2023Buy Now40.62%Rosenblatt
Mike Genovese69%
$16 → $13MaintainsBuyGet Alert
02/03/2023Buy Now46.02%B. Riley Securities
Dave Kang74%
$14.5 → $13.5MaintainsNeutralGet Alert
12/20/2022Buy Now18.98%JP Morgan
Samik Chatterjee70%
$13 → $11MaintainsNeutralGet Alert
12/02/2022Buy Now29.8%Stifel
Ruben Roy81%
→ $12Initiates → HoldGet Alert
11/07/2022Buy Now40.62%Morgan Stanley
Meta Marshall77%
$16 → $13MaintainsEqual-WeightGet Alert
11/04/2022Buy Now56.84%B. Riley Securities
Dave Kang74%
$21 → $14.5DowngradeBuy → NeutralGet Alert
10/11/2022Buy Now73.07%Morgan Stanley
Meta Marshall77%
$17 → $16MaintainsEqual-WeightGet Alert
10/06/2022Buy Now94.7%Rosenblatt
Mike Genovese69%
→ $18Initiates → BuyGet Alert
09/14/2022Buy Now83.88%Morgan Stanley
Meta Marshall77%
$16 → $17MaintainsEqual-WeightGet Alert
08/12/2022Buy Now94.7%Susquehanna
Mehdi Hosseini64%
$20 → $18MaintainsPositiveGet Alert
07/19/2022Buy NowNeedham
Alex Henderson84%
DowngradeBuy → HoldGet Alert
07/14/2022Buy Now62.25%JP Morgan
Samik Chatterjee70%
$18 → $15MaintainsNeutralGet Alert

FAQ

Q

What is the target price for Viavi Solutions (VIAV) stock?

A

The latest price target for Viavi Solutions (NASDAQ:VIAV) was reported by UBS on May 2, 2025. The analyst firm set a price target for $11.00 expecting VIAV to rise to within 12 months (a possible 18.98% upside). 25 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Viavi Solutions (VIAV)?

A

The latest analyst rating for Viavi Solutions (NASDAQ:VIAV) was provided by UBS, and Viavi Solutions maintained their neutral rating.

Q

When was the last upgrade for Viavi Solutions (VIAV)?

A

The last upgrade for Viavi Solutions Inc happened on March 7, 2025 when Rosenblatt raised their price target to $14. Rosenblatt previously had a neutral for Viavi Solutions Inc.

Q

When was the last downgrade for Viavi Solutions (VIAV)?

A

The last downgrade for Viavi Solutions Inc happened on December 17, 2024 when Morgan Stanley changed their price target from $8 to $9.5 for Viavi Solutions Inc.

Q

When is the next analyst rating going to be posted or updated for Viavi Solutions (VIAV)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viavi Solutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viavi Solutions was filed on May 2, 2025 so you should expect the next rating to be made available sometime around May 2, 2026.

Q

Is the Analyst Rating Viavi Solutions (VIAV) correct?

A

While ratings are subjective and will change, the latest Viavi Solutions (VIAV) rating was a maintained with a price target of $11.50 to $11.00. The current price Viavi Solutions (VIAV) is trading at is $9.24, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch